COMMUNIQUÉS West-GlobeNewswire

Golden Leaf Announces Closing of Acquisition of Medical Marijuana Group Consulting Ltd.

02/01/2018 - 14:00

TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, is pleased to announce that [...]

AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference

02/01/2018 - 12:30

SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

Transactions in relation to share buyback program

02/01/2018 - 12:22

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

ContraVir Pharmaceuticals to Present at Biotech Showcase 2018

02/01/2018 - 12:00

EDISON, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Hepatocellular Carcinoma

02/01/2018 - 12:00

CAMBRIDGE, Mass. and BEIJING, China, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 December 2017)

02/01/2018 - 11:15

Bagsværd, Denmark, 2 January 2018 - In continuation of the company's announcements dated 9 August 2017 and 1 November 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York [...]

HealthLynked Corp. Announces release of its Medical Newsfeed Service for Members and Providers

02/01/2018 - 11:00

NAPLES, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the release of its new design with the introduction of its newsfeed service. The new design allows members to access the [...]

Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

02/01/2018 - 09:05

VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in [...]

How assessURhealth™ worked to #EndTheStigma in 2017

01/01/2018 - 15:29

Tampa, Jan. 01, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of mental and behavioral health screening software, took their mission to new heights in 2017. Expanding their integration capabilities [...]

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017

31/12/2017 - 18:00

Company Release no. 27/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017 Veloxis Pharmaceuticals A/ [...]

Helius Medical Technologies Announces Closing of Final Tranche of Private Placement

30/12/2017 - 00:45

NEWTOWN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30/12/2017 - 00:00

CAMBRIDGE, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma

29/12/2017 - 22:46

HAMILTON, Bermuda and NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS ) (SELLAS Inc.) today announced that the proposed merger of the businesses of SELLAS Life Sciences Group [...]

Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis

29/12/2017 - 22:05

BERKELEY HEIGHTS, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life- [...]

Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook

29/12/2017 - 22:01

HOUSTON, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System

29/12/2017 - 22:00

ATLANTA, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]

ContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer

29/12/2017 - 22:00

EDISON, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), announced today that John Sullivan-Bolyai will step down as Chief Medical Officer and take on a new role in the company, [...]

United American Healthcare Corporation’s Subsidiaries show strong Third Quarter Fiscal Year 2017 Results

29/12/2017 - 21:24

CHICAGO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (the “Company”), today announced that it plans to release its consolidated financial operational results for the three and nine months [...]

Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference

29/12/2017 - 19:47

WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing flexibility and [...]